JPS6170999A - Production of cephalosporin compound - Google Patents

Production of cephalosporin compound

Info

Publication number
JPS6170999A
JPS6170999A JP19234584A JP19234584A JPS6170999A JP S6170999 A JPS6170999 A JP S6170999A JP 19234584 A JP19234584 A JP 19234584A JP 19234584 A JP19234584 A JP 19234584A JP S6170999 A JPS6170999 A JP S6170999A
Authority
JP
Japan
Prior art keywords
acetoxymethyl
compound
solution
cephalosporin
bran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP19234584A
Other languages
Japanese (ja)
Other versions
JPH0468919B2 (en
Inventor
Hiroki Kuroda
黒田 宏紀
Akihiko Miyadera
宮寺 彰彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP19234584A priority Critical patent/JPS6170999A/en
Publication of JPS6170999A publication Critical patent/JPS6170999A/en
Publication of JPH0468919B2 publication Critical patent/JPH0468919B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:To obtain a cephalosporin compound wherein acetoxymethyl at the 3-position is converted into hydroxymethyl group by eliminating advantageously acetyl group from the acetoxymethyl without causing side reactions, by treating a cephalosporin compound with wheat bran. CONSTITUTION:(A) A cephalosporin compound such as cephalosporin C, 3- acetoxymethyl-7beta-amino-3-cephem-4-carboxylic acid, cephaloglycin, etc. is processed into preferably 1-50mg/ml aqueous solution, (B) wheat bran such as barley bran is washed with water to remove impurities, the component A is blended with 4-40 times calculated as weight before water washing as much barley as the component A. The component A is treated with the barley bran at 6-8pH for 24hr, the barley bran is filtered off, the filtrate is subjected to ultrafiltration to remove colored substances and protein, the solution is evaporated to dryness, or an organic solvent such as an alcohol, etc. is added to the solution, and a substance is precipitated, to give the aimed substance.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、セファセスポリン化合物の製造法に関するも
のである。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for producing a cephacesporin compound.

゛ 化学療法剤として有用なセファロスポリン化合物は
セフェム構造を有しており、その8位と7位に種々の置
換基を導入することにより特色ある抗菌活性が発揮され
る。
Cephalosporin compounds useful as chemotherapeutic agents have a cephem structure, and exhibit unique antibacterial activity by introducing various substituents into the 8- and 7-positions.

これらの化合物を製造する際に繁用される原料は、セフ
ァ鴛スポリンC(以下CPCと略称する)および3−ア
セトキシメチルー7β−アミノ−8−セフェム−4−カ
ルボン酸(以下7−ACAと略称する)である。ところ
が、これらの化合物の3位には、不活性なアセトキシメ
チル基が存在するため、3位に置換基導入を試みる場合
には、まず脱アセチル化を行って活性なヒドロキシメチ
ル中間体を製造する事が必須である。
The raw materials often used in the production of these compounds are Cephalosporin C (hereinafter referred to as CPC) and 3-acetoxymethyl-7β-amino-8-cephem-4-carboxylic acid (hereinafter referred to as 7-ACA). (abbreviated). However, since an inactive acetoxymethyl group exists at the 3-position of these compounds, when attempting to introduce a substituent at the 3-position, deacetylation is first performed to produce an active hydroxymethyl intermediate. things are essential.

〔従来の技術〕[Conventional technology]

セファロスポリン化合物の3位のアセトキシメチル基か
らアセチル基を離脱させ、ヒドロキシメチル基に導く方
法としては、酸またはアルカリ水溶液を加えて化学的に
切断する方法と酵素で緩和に加水分解する方法とがある
There are two methods for removing the acetyl group from the acetoxymethyl group at the 3-position of a cephalosporin compound and converting it into a hydroxymethyl group: chemical cleavage by adding an acid or alkaline aqueous solution, and mild hydrolysis with an enzyme. There is.

苛性ソーダや塩酸の如き化学的加水分解試薬による方法
は9元来不安定なセフテロスポリン化合物の分解を招き
やすいため、工業的には困難の伴なう−20〜−40℃
の様な低温域での操作が必要であり、それにも拘らず酸
性試薬との反応では8位に生成したヒドロキシメチル基
と4位のカルボキシル基との間にラクトン環が形成され
たり、アルカリ試薬では2型詰合(Δ3)の転移した6
2体が副生じやすい。
Methods using chemical hydrolyzing reagents such as caustic soda and hydrochloric acid tend to cause decomposition of the inherently unstable cefterosporin compound, which is difficult to achieve industrially at -20 to -40°C.
However, in the reaction with an acidic reagent, a lactone ring is formed between the hydroxymethyl group formed at the 8-position and the carboxyl group at the 4-position, and when an alkaline reagent Now, the transferred 6 of type 2 packing (Δ3)
Two bodies are likely to occur as side effects.

一方緩和な条件で反応を進め得る酵素的脱アセチル化方
法としては(イ)柑橘類の果皮から導かれたエステラー
ゼを使用する方法(英国特許996.222)、(ロ)
小麦胚芽エステラーゼを用いる方法(特公昭42−15
53)、(ハ)バチルス・ズブチリス等の微生物酵素で
加水分解する方法(特公昭49−85993)が知られ
ているが、これらについても、工業的な観点からはなお
種々の問題が残されている。例えば、(イ)の方法では
、酵素源となる均一な果皮の入手が困難であり、仲)の
方法では、酵素源は比較的容易に入手できるものの、エ
ステラーゼを抽出・精製して用いなければならず、その
操作が極めて繁雑である。一方、(ハ)の方法などの工
業的には最も有望視されている微生物酵素では、各菌種
により程度の差はあるが、β−ラクタム環を開裂させる
酵素(β−ラクタマーゼ)の混入が避は得ず収率や純度
の低下原因となる欠点を有している。
On the other hand, enzymatic deacetylation methods that allow the reaction to proceed under mild conditions include (a) a method using esterase derived from citrus peel (British Patent No. 996.222);
Method using wheat germ esterase (Special Publication Publication No. 42-15
53), (c) Methods of hydrolysis using microbial enzymes such as Bacillus subtilis (Japanese Patent Publication No. 49-85993) are known, but these still have various problems from an industrial perspective. There is. For example, in method (a), it is difficult to obtain uniform pericarp as an enzyme source, and in method (naka), although the enzyme source is relatively easy to obtain, the esterase must be extracted and purified before use. The operation is extremely complicated. On the other hand, with the microbial enzymes that are considered the most promising industrially, such as the method (c), although there are differences in degree depending on the bacterial species, contamination with an enzyme (β-lactamase) that cleaves the β-lactam ring is a problem. It inevitably has drawbacks that cause a decrease in yield and purity.

そこで2本発明者等は、3位側鎖の酵素的脱アセチル化
を行なうに際し、大量安価に入手でき且つ精製が簡単な
酵素源を用い、副反応を伴なわない有利な製造法につい
て種々検討の結果本発明を完成した。
Therefore, the present inventors conducted various studies on an advantageous production method that does not involve side reactions when carrying out enzymatic deacetylation of the 3-position side chain, using an enzyme source that can be obtained in large quantities at low cost and is easy to purify. As a result, the present invention was completed.

〔発明の構成〕[Structure of the invention]

本発明は、一般式   ゛ で表わされる化合物を皺(ふすま)で処理して一般式 で表わされる化合物を製造する方法である。ただし、R
tは水素またはアシル基を意味し、R2は低級アルキル
基を意味する。−はカルボキシル基もしくはその塩また
は保護されたカルボキシル基を量論する。
The present invention is a method for producing a compound represented by the general formula by treating the compound represented by the general formula with wrinkles (bran). However, R
t means hydrogen or an acyl group, and R2 means a lower alkyl group. - stoichiometrically represents a carboxyl group or a salt thereof or a protected carboxyl group.

化合物(I)としてはapaや7−ACAの他にもセフ
ァログリシン(R1: C5HsCjH(N)Iz)0
0− ) +セファロチン(R1’ 0GHx00− 
) rセファピリン(R1: NG5C1hCO−) 
、  セ7オタキシム(R1ニルアミノ基である化合物
があり、このアシル基上記のほかにアシル基の例として
は、2−        □の相違によって3位のアシ
ルオキシメチル基の脱アシル反応が影響されることは殆
んどない。・(2−アミノチアゾール−4−イル)−2
−((イミダゾール−4−イル)メトキシイミノ)アセ
チル基や特公昭58−43979号公報に示されたもの
などを挙げることができる。
In addition to apa and 7-ACA, compound (I) also includes cephaloglycin (R1: C5HsCjH(N)Iz)0
0-) + cephalothin (R1' 0GHx00-
) rcephapirin (R1: NG5C1hCO-)
, There is a compound with se7 otaxime (R1 nylamino group), and this acyl group In addition to the above, as an example of an acyl group, the deacylation reaction of the 3-position acyloxymethyl group is not affected by the difference in 2-□. Almost none.・(2-aminothiazol-4-yl)-2
Examples include -((imidazol-4-yl)methoxyimino)acetyl group and those shown in Japanese Patent Publication No. 58-43979.

反応液中の化合物(1)の濃度は1通常1〜50■/g
IItの範囲であるが、脱アシル反応の速度が大きいた
め更に高濃度でも可能である。
The concentration of compound (1) in the reaction solution is usually 1 to 50 μ/g.
Although the concentration is in the range of IIt, even higher concentrations are possible because the rate of the deacylation reaction is high.

皺としては、安価かつ大量に入手できる小麦鼓が好適で
あり1表面に付着している不純物を−乃至数回の水洗浄
により除去して使用するのが好ましい。使用量は水洗前
の重量で、基質(化合物(I))に対して4〜40倍重
量が普通である。
Wheat drums, which are inexpensive and available in large quantities, are suitable for the wrinkles, and it is preferable to use them after removing impurities adhering to the surface by washing with water one to several times. The amount used is the weight before washing with water, and is usually 4 to 40 times the weight of the substrate (compound (I)).

反応を行なうには、化合物(I)の水溶液に水洗浄した
皺を加え、pH6〜8好ましくはpH6,5〜7.0に
保ち、20〜40″C好ましくは25〜30°Cで2〜
24時間1時間1ラ常18時間処理する。この際、リン
酸緩衝液等の通常の緩衝液を用いることができるが、緩
衝液を用いずに、脱゛アシルにより生じた遊離の酸例え
ば酢酸を適宜アルカリで中和しながら反応を行なうごと
も可能である。
To carry out the reaction, add water-washed wrinkles to an aqueous solution of compound (I), maintain the pH at 6-8, preferably pH 6,5-7.0, and heat at 20-40"C, preferably 25-30"C.
Process for 24 hours, 1 hour, and 18 hours a day. At this time, a normal buffer such as a phosphate buffer can be used, but it is also possible to carry out the reaction without using a buffer, while neutralizing the free acid generated by deacylation, such as acetic acid, with an alkali as appropriate. is also possible.

反応終了液から目的化合物(I[)を単離するには。To isolate the target compound (I[) from the reaction-completed solution.

皺を濾去等の操作で除去し9次いで限外濾過により着色
物質、蛋白等を除き、得られる液を乾固するか、または
この溶液にアルコール、アセトン、エーテルの如き有機
溶媒を加えて目的物を析出させるのが一般的である。限
外濾過は。
The wrinkles are removed by an operation such as filtration, colored substances, proteins, etc. are removed by ultrafiltration, and the resulting liquid is dried, or an organic solvent such as alcohol, acetone, or ether is added to this solution to obtain the desired solution. It is common to precipitate substances. Ultrafiltration.

酢酸セルロース系、ポリアミド系、ポリスルホン系、ポ
リアクリロニトリル系等の市販の限外濾過膜を単一また
は組合せて適宜使用することができる。
Commercially available ultrafiltration membranes such as cellulose acetate, polyamide, polysulfone, and polyacrylonitrile may be used singly or in combination as appropriate.

実施例1 セファロスポリンCナトリウム塩・2水和物5ooqを
0,1Mリン酸緩衝液(pH7,−0)100−に溶解
し、小麦麩2gを加え、80℃で13時間攪拌した。
Example 1 5 ooq of cephalosporin C sodium salt dihydrate was dissolved in 100-ml of 0.1 M phosphate buffer (pH 7, -0), 2 g of wheat gluten was added, and the mixture was stirred at 80°C for 13 hours.

鼓を濾去後1反応液を液体クロマトグラフィーで分析し
たところ3−ヒドロキシメチル−7β−(D−5−アミ
ノ−5−カルボキシペンタンアミド)−8−セフェム−
4−カルボン酸の生成率は95%であった0この反応液
を限外濾過した後、非イオン性多孔性ポリマー樹脂HP
−20(三菱化成)504に通液し、流出液をpH7:
5に調整し゛た、後、凍結乾燥して8−とド四キシメチ
ル体のす1上リウム塩・8.5水和物4a7q(純度9
6.1%)を得た。
After the drum was filtered off, one reaction solution was analyzed by liquid chromatography, and it was found that 3-hydroxymethyl-7β-(D-5-amino-5-carboxypentanamide)-8-cephem-
The production rate of 4-carboxylic acid was 95%. After ultrafiltration of this reaction solution, nonionic porous polymer resin HP
-20 (Mitsubishi Kasei) 504, and the effluent has a pH of 7:
After adjusting the concentration to
6.1%).

この乾固物を水−エタノールで再結晶して得た精製結晶
は、NMRδ(Dis、 020 ) −4,4(2H
,S、 O蜘OH)、(α)”+107°(H,O。
The purified crystal obtained by recrystallizing this dry product with water-ethanol has an NMR δ (Dis, 020) -4,4 (2H
, S, O spider OH), (α)”+107° (H, O.

O−2,0)t E:、:2603fi−185を示し
標品と一致した。
O-2,0)tE:, :2603fi-185, which matched the standard product.

実施例2 実施例1におけるセファロスポリンCの代りに3−アセ
トキシメチル−7β−アミノ−8−化7エムー4−カル
ボン酸(7−ACA)を使用し、小麦麩を1a−g使用
する以外は実施例1と同様に処理し、5時間反応させた
。反応液を液体クロマトグラフィーで分析すると、3−
ヒドロキシメチル−7β−アミノセフ−3−エム−4−
カルボン酸の生成率は100%であった。
Example 2 Except for using 3-acetoxymethyl-7β-amino-8-conjugated 7emu-4-carboxylic acid (7-ACA) in place of cephalosporin C in Example 1 and using wheat wheat 1a-g. was treated in the same manner as in Example 1, and reacted for 5 hours. When the reaction solution was analyzed by liquid chromatography, 3-
Hydroxymethyl-7β-aminocef-3-em-4-
The production rate of carboxylic acid was 100%.

鼓を濾来後、濾液を限外濾過し9次いでHP−2050
艷に通液し流出液を約5−まで濃縮し、酢酸でpHtr
:4.2に調整した。この濃縮液を氷冷し、析出物を濾
取乾燥し、3−ヒドロキシメチル体308■を得た。本
品のNMRはδ(DSS、 DzO)−4,2(2H,
8,C也OH)及びTLc(n−ブタノール:酢酸:ビ
リジン:水−15=3:10:12)はRf−0,37
を示し標品と一致した。
After filtering the drum, the filtrate was ultrafiltered and then HP-2050
Concentrate the effluent to approximately 5-50% by passing the liquid through the bar, and adjust the pH value with acetic acid.
:Adjusted to 4.2. This concentrated solution was cooled with ice, and the precipitate was collected by filtration and dried to obtain 308 ml of 3-hydroxymethyl compound. The NMR of this product is δ(DSS, DzO)-4,2(2H,
8, COH) and TLc (n-butanol:acetic acid:pyridine:water-15=3:10:12) are Rf-0,37
The result was consistent with the standard product.

実施例3 ・3−アセトキシメチル−7β−(2−(2−アミノチ
アゾール−4−イル)−2−((イミダゾール−1−イ
ル)メトキシイミノ)アセトアミドツー3−セフェム−
4−カルボン酸・二塩酸塩5QO■を水100−に溶解
し、0.05N−水酸化ナトリウム液でpH7,0に調
整した。
Example 3 - 3-acetoxymethyl-7β-(2-(2-aminothiazol-4-yl)-2-((imidazol-1-yl)methoxyimino)acetamido-3-cephem-
4-Carboxylic acid dihydrochloride 5QO■ was dissolved in 100% water and adjusted to pH 7.0 with 0.05N sodium hydroxide solution.

この溶液に、小麦麩4gを冷水20−で5回洗浄したも
のを加え、0.05N−水酸化ナトリウムで系内pHを
7.0に保ちつ\80℃で13時間反応させた。
To this solution was added 4 g of wheat gluten which had been washed 5 times with 20°C of cold water, and the mixture was reacted at 80°C for 13 hours while the system pH was maintained at 7.0 with 0.05N sodium hydroxide.

皺を濾去後9反応液を液体クロマトグラフィーで分析し
たところ、3−ヒドロキシメチル−7β−(2−(2−
アミノチアゾール−4−イル)−2−((イミダゾール
−4−イル)メトキシイミノ)アセトアミドツー3−セ
フェム−4−カルボン酸の生成率は95.2%であった
After removing the wrinkles by filtration, the nine reaction solutions were analyzed by liquid chromatography, and the results showed that 3-hydroxymethyl-7β-(2-(2-
The production rate of aminothiazol-4-yl)-2-((imidazol-4-yl)methoxyimino)acetamido-3-cephem-4-carboxylic acid was 95.2%.

この反応液を限外濾過後、HP−205Qm/に通液し
、その流出液を凍結乾燥し8−ヒドロキシメチル体36
2■(無水物換算)を得た。
After ultrafiltration, this reaction solution was passed through HP-205Qm/, and the effluent was freeze-dried to obtain 8-hydroxymethyl compound 36.
2■ (calculated as anhydride) was obtained.

本品のNMRはδ(DSL、 DzO)−4,35(2
H,s、 030H)、 I Rはνmax(KBr 
) −1760,1650,1600を示し、その構造
を支持した。
The NMR of this product is δ(DSL, DzO)-4,35(2
H, s, 030H), I R is νmax(KBr
) -1760, 1650, 1600 and supported the structure.

実施例4 実施例8における原料化合物の代りにセ7オタキシムナ
トリウムを使用し、小麦麩8りを冷水40−で5回洗浄
して使用する以外は、実施例8と同様に処理し9反応さ
せた。反応液を液体クロマト分析すると、3−ヒドロキ
シメチル−7β−(2−(2−アミノチアゾール−4−
イル)−2−メトキシイミノアセトアミド〕−3−七7
!ムー4−カルボン酸ナトリウムの生成率は94.7%
であった。
Example 4 The same procedure as in Example 8 was carried out, except that ce7-otaxime sodium was used instead of the raw material compound in Example 8, and the wheat gluten was washed 5 times with 40 cm of cold water before use. I let it happen. Liquid chromatography analysis of the reaction solution revealed that 3-hydroxymethyl-7β-(2-(2-aminothiazole-4-
yl)-2-methoxyiminoacetamide]-3-77
! The production rate of sodium mu-4-carboxylate is 94.7%
Met.

得られた反応液は実施例8と同様に後処理して8−ヒド
ロキシメチル体401119(無水物換算)を得た0本
品のNMRは、δ(D S S、 D20 )=4.8
5 (2H,8,CjlzOH)、 X Rはνmax
(KBr)−1760を示し標品と一致した。
The obtained reaction solution was post-treated in the same manner as in Example 8 to obtain 8-hydroxymethyl compound 401119 (in terms of anhydride). The NMR of this product was δ(DSS, D20) = 4.8
5 (2H,8,CjlzOH), X R is νmax
(KBr)-1760, which was consistent with the standard product.

実施例5 実施例2における?−AOAの代りにセファロチンナト
リウム塩を使用し、それ以外は実施例2と同様に処理し
反応させた。反応液を液体クロマトグラフィー分析する
と8−ヒドロキシメチル−7β−(チオ7エンー2−イ
ルア七ドアミド)−3−セフェム−4−カルボン酸ナト
リウムの生成率は97.9%であった。得られた反応液
に食塩を添加後、 pH3,5に調整し、酢酸エチルで
抽出し、酢酸エチル層を濃縮乾固する。残留液をメタノ
ールで再結晶して3−ヒドロキシメチル体の結晶を得た
。本品はNMRδ(D 19 S、珈0 )−4,4(
2H,s、 0也OH)及びUVλmax260am(
4−8050)より、標品と同定した◎ 実施例6 実施例2における?−ACAの代りにセファピリンナト
リウム嶌を使用する以外は、実施例2と同様に処理し2
反応させた。反応液を液体クロマトグラフィーで分析す
ると8−ヒドロキジメチルーフβ−(ピリド−4−イル
チオア七タミド)−3−セフェム−4−カルボン酸ナト
リウムの生成率は97.2%であった。
Example 5 In Example 2? - Cephalothin sodium salt was used instead of AOA, and the reaction was carried out in the same manner as in Example 2 except for the above. Liquid chromatography analysis of the reaction solution revealed that the production rate of sodium 8-hydroxymethyl-7β-(thio7en-2-yla-7doamide)-3-cephem-4-carboxylate was 97.9%. After adding sodium chloride to the resulting reaction solution, the pH was adjusted to 3.5, extracted with ethyl acetate, and the ethyl acetate layer was concentrated to dryness. The residual liquid was recrystallized with methanol to obtain crystals of 3-hydroxymethyl compound. This product has NMRδ(D19S, C0)-4,4(
2H,s, 0yaOH) and UVλmax260am(
4-8050), it was identified as the standard sample. ◎ Example 6 In Example 2? - Treated as in Example 2, except using Cephapirin Sodium instead of ACA.
Made it react. Analysis of the reaction solution by liquid chromatography revealed that the production rate of sodium 8-hydroxydimethyl-[beta]-(pyrid-4-ylthio-7tamide)-3-cephem-4-carboxylate was 97.2%.

得られた反応液は実施例8と同様に後処理して3−ヒド
ロキシメチル体の結晶を得、そのN  MRδ(Dss
、珈0 )=4.2 (2H,s、 GHs、OH)よ
り標品と同定した。
The obtained reaction solution was post-treated in the same manner as in Example 8 to obtain crystals of the 3-hydroxymethyl compound, and its N MRδ (Dss
, C0)=4.2 (2H,s, GHs,OH), it was identified as the standard specimen.

実施例7 実施例2における7−ACAの代りにセフテ四グリシン
・2水和物を使用し、小麦皺を20り使用する以外は実
施例2と同様に処理し2.5時間反応させた。反応液を
液体クセマドグラフィーで分析すると3−ヒドロキシメ
チル−7β−(D−α−アミノフェニルアセタミド)−
8−セフェム−4−カルボン酸の生成率は95.0%で
あった。
Example 7 The same procedure as in Example 2 was repeated except that ceftetetraglycine dihydrate was used in place of 7-ACA in Example 2, and 20 g of wheat bran was used, and the reaction was carried out for 2.5 hours. When the reaction solution was analyzed by liquid chromatography, 3-hydroxymethyl-7β-(D-α-aminophenyl acetamide)-
The production rate of 8-cephem-4-carboxylic acid was 95.0%.

得られた反応液から実施例3と同様にして単離した3−
ヒドロキシメチル体の結晶はNMR(Dss、D2o)
δ−4,2(2He Is、 Cji20H)及びUV
  2max260s@(a−8400)  より標品
と同定した。
3- isolated from the resulting reaction solution in the same manner as in Example 3.
Crystals of hydroxymethyl form are NMR (Dss, D2o)
δ-4,2 (2He Is, Cji20H) and UV
2max260s@(a-8400) It was identified as the standard product.

Claims (1)

【特許請求の範囲】 一般式 ▲数式、化学式、表等があります▼ で表わされる化合物を麩で処理することを特徴とする一
般式 ▲数式、化学式、表等があります▼ で表わされる化合物の製造法。ただし、R_1は水素ま
たはアシル基を意味し、R_2は低級アルキル基を意味
する。R_3はカルボキシル基もしくはその塩または保
護されたカルボキシル基を意味する。
[Claims] Manufacture of a compound represented by the general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ characterized by treating the compound represented by the general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ Law. However, R_1 means hydrogen or an acyl group, and R_2 means a lower alkyl group. R_3 means a carboxyl group, a salt thereof, or a protected carboxyl group.
JP19234584A 1984-09-13 1984-09-13 Production of cephalosporin compound Granted JPS6170999A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19234584A JPS6170999A (en) 1984-09-13 1984-09-13 Production of cephalosporin compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19234584A JPS6170999A (en) 1984-09-13 1984-09-13 Production of cephalosporin compound

Publications (2)

Publication Number Publication Date
JPS6170999A true JPS6170999A (en) 1986-04-11
JPH0468919B2 JPH0468919B2 (en) 1992-11-04

Family

ID=16289727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19234584A Granted JPS6170999A (en) 1984-09-13 1984-09-13 Production of cephalosporin compound

Country Status (1)

Country Link
JP (1) JPS6170999A (en)

Also Published As

Publication number Publication date
JPH0468919B2 (en) 1992-11-04

Similar Documents

Publication Publication Date Title
US5525483A (en) Process for preparation of β-lactams utilizing a combined concentration of acylating agent plus β-lactam derivative of at least 400 mm
JPS5946954B2 (en) Antibiotic manufacturing method
NO143834B (en) GAS FILTER ELEMENT.
KR102301469B1 (en) Production of galacto-oligosaccharides
US4012382A (en) α-Amino and α-formyl-α-(p-acyloxyphenyl)acetamidocephalosporanic acid derivatives
JPH02311483A (en) Preparation of ceftriaxone
WO2014072843A1 (en) Process for preparing isoxazolyl penicillins
EP2048240A2 (en) Process for producing 7-methoxy-3-desacetylcefalotin
US4053360A (en) Enzymatic preparation of 6-D-(-)-α-amino-α-(p-hydroxyphenylacetamino)penicillin acid
JPS6170999A (en) Production of cephalosporin compound
CZ241997A3 (en) Cephalexin isolation process
JP2002509933A (en) A new method for fermentative production of cephalosporins
US4113941A (en) Process for purifying products obtained from enzymatic cleavage of beta-lactam antibiotics
JPH0453499A (en) Production of deacetyl-7-aminocephalosphoranic acid
JPS5919557B2 (en) N↑6-substituted cordycepin derivative and method for producing the same
US5831085A (en) Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
EP0430307A1 (en) The use of moranoline and its derivatives as stabilizing agent for enzymes
US4204058A (en) Process for obtaining cephalosporin C and the salts and derivatives thereof from culture filtrates or culture solutions
JPS625988A (en) Cephem or cepham compound and production thereof
JPS63500721A (en) New manufacturing method for chemical compounds
US3879409A (en) Isolation of 6-aminopenicillanic acid and salts thereof
AT365595B (en) METHOD FOR PRODUCING NEW CEPHEM COMPOUNDS
CA1056814A (en) Formyl-(p-acyloxyphenyl) acetamidocephalosporanic acid derivatives
JPH04330297A (en) Production of l-threo-3-(3,4-dihydroxyphenyl)serine derivative
JPH03176473A (en) Pyridine-n-oxide derivative and its preparation